Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Areas of Research Interest
| Protocol Type | Tirzepatide Dose | 5-Amino-1MQ Dose | Administration Frequency | Expected Mechanism | Typical Observation Window | Professional Assessment | ||||||| | Tirzepatide Monotherapy | 2.515mg weekly (titrated) | None | Weekly subcutaneous injection | GLP-1/GIP receptor agonism reduces appetite and slows gastric emptying | 1220 weeks to plateau | Proven efficacy in human trials
Ordered 242 orders in the last 30 days With Royal Mail 93% by the time we promised median 16h 50m Delivered 78% next working day median 0.9 days in transit Legal & safety: Simply Peptides supplies FOXO4-DRI strictly for in vitro research use only
The Peptide Gray Market: Who's White-Labeling "Research Only" Vials, and What's Actually Inside Them An evidence-based look at the supply chain behind the peptide boom, the FDA's whiplash on compounding, and the published data on what's really in those vials
Promotes a smoother and more youthful-looking appearance
GHK-Cu is naturally occurring, non-toxic, and effective at very low concentrations
US$ 23.91
US$ 25.17
US$ 26.21
US$ 29.08
US$ 26.72
US$ 21.51
US$ 24.01
US$ 28.74
US$ 22.29
US$ 21.47
US$ 22.87
